Cargando…
Novel antibody probes for the characterization of endosialin/TEM-1
Endosialin (Tumor Endothelial Marker-1 (TEM-1), CD248) is primarily expressed on pericytes of tumor-associated microvasculature, tumor-associated stromal cells and directly on tumors of mesenchymal origin, including sarcoma and melanoma. While the function of endosialin/TEM-1 is incompletely underst...
Autores principales: | O'shannessy, Daniel J., Smith, Michael F., Somers, Elizabeth B., Jackson, Stephen M., Albone, Earl, Tomkowicz, Brian, Cheng, Xin, Park, Young, Fernando, Danielle, Milinichik, Andrew, Kline, Brad, Fulton, Regan, Oberoi, Pankaj, Nicolaides, Nicholas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342488/ https://www.ncbi.nlm.nih.gov/pubmed/27494870 http://dx.doi.org/10.18632/oncotarget.11018 |
Ejemplares similares
-
Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins
por: O'Shannessy, Daniel J., et al.
Publicado: (2014) -
Development of (89)Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications
por: Lange, Sara E.S., et al.
Publicado: (2016) -
Characterization of the Human Folate Receptor Alpha Via Novel Antibody-Based Probes
por: O'Shannessy, Daniel J., et al.
Publicado: (2011) -
Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
por: Nicolaides, Nicholas C., et al.
Publicado: (2014) -
Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies
por: O'Shannessy, Daniel J., et al.
Publicado: (2016)